title: [Evaluation of clinical usefulness of selected laboratory markers in the prediction of myocardial infarction in patients under secondary prevention].
abstract: The aim of the study was to evaluate the range of chronic inflammation in patients after second or subsequent myocardial infarction, and to compare it with its range in patients after first MI.
  
  
  METHODS
  C-reactive protein measurement clinical value was examined by high sensitivity CRP method (hsCRP) and compared to clinical value of other heart attack risk factors: total cholesterol (TC) and cholesterol in HDL fraction (HDL-C), triglycerides (TG) and fibrinogen (FBG). The research included 120 patients in two investigated groups: Z2--30 patients undergoing secondary prevention after second (subsequent) heart attack, and Z1--30 patients with first myocardial infarction. There were two reference groups: KOR--30 people undergoing planned coronarography and K--30 healthy individuals. Groups Z2, Z1 and KOR patients were treated with PCI (percutaneous coronary intervention).
  
  
  RESULTS
  HsCRP medians for group Z2 (2.65 mg/I) and groups Z, (2.25 mg/) and KOR (2.35 mg/l) were significantly higher than in group K (1.10 mg/dl).
  
  
  CONCLUSIONS
  Highest clinical value of hsCRP in coronary attack prediction was confirmed. Relative area under ROC curve (AUC) was highest in group 2, higher than in group Z1 (0.778 and 0.711, respectively). In patients undergoing secondary prevention, group Z2, hsCRP measurement showed higher clinical value in subsequ ent myocardial infarction prediction than in first one. In groups Z2 and Z1, HDL-C measurement also shows high diagnostic value for coronary risk assessment. AUC are 0.875 and 0.782, respectively. However, in treatment with statins, high AUC values do not necessarily reflect myocardial infarction risk.
authors.affiliation: ZOZ MSWiA w todzi, Zakład Diagnostyki Laboratoryjnej. zdl.lodz@wp.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Plak
authors.forename: Marek
authors.initials: M
authors.lastname: Łobos
authors.forename: Wojciech
authors.initials: W
authors.lastname: Religa
authors.forename: Aldona
authors.initials: A
authors.lastname: Tokarek
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Bonar
authors.forename: Beata
authors.initials: B
authors.lastname: Janas
authors.forename: Marek
authors.initials: M
authors.lastname: Paradowski
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000032:analysis; D002097:C-Reactive Protein; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000517:prevention & control*; D018570:Risk Assessment; D055502:Secondary Prevention; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D002097:C-Reactive Protein